A method for evaluating drug effects on intermittent claudication using a treadmill in rats with unilateral hindlimb artery occlusion

Journal of Pharmacological and Toxicological Methods

Volumn 49, Issue 1, 2004, Pages 25-29

  Orito, Kensuke ^a,b   Kishi, Masami ^a   Fujiki, Hiroyuki ^a   Nakazawa, Toru ^a   Imaizumi, Takashi ^a   Kimura, Yukio ^a   Mori, Toyoki ^a   Kambe, Toshimi ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b AZABU UNIVERSITY   (Japan)

Author keywords

Claudication; Gait disturbance; Method; Peripheral vascular disease; Pharmacology

Indexed keywords

CILOSTAZOL; DRUG VEHICLE;

ANIMAL EXPERIMENT; ARTERY OCCLUSION; ARTICLE; DRUG EFFECT; GAIT; HINDLIMB; ILIAC ARTERY; ILIAC ARTERY OBSTRUCTION; IN VIVO STUDY; INTERMITTENT CLAUDICATION; MALE; NONHUMAN; PERIPHERAL ISCHEMIA; RAT; SUPERFICIAL FEMORAL ARTERY; TREADMILL;

EID: 0344737058     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2003.08.001     Document Type: Article

References (19)

1. Akiyama H., Kudo S., Shimizu T. The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittel-Forschung Drug Research. 35:1985;1124-1132.
2. Bagger J.P., Helligsoe P., Randsbaek F., Kimose H.H., Jansen B.S. Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment. Circulation. 95:1997;411-414.
3. Balsano F., Coccheri S., Libretti A., Nenci G.G., Catalano M., Fortunato G., Grasselli F., Violi F., Hellemans H., Vanhove P.H. Ticlopidine in the treatment of intermittent claudication: A 21-month double-blind trial. Journal of Laboratory and Clinical Medicine. 114:1989;84-91.
4. Crowder J.E., Cohn J.B., Savitsky J.P., Morgan D.L., Slywka J., Cobert B.L., Hryniewicki S.W., Piccirillo R.T., Wilcox C.S. Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. Angiology. 40:1989;795-802.
5. Dawson D.L., Cutler B.S., Meissner M.H., Strandness D.E. Cilostazol has beneficial effects in treatment of intermittent claudication: Results from a multicenter, randomized, prospective, double-blind trial. Circulation. 98:1998;678-686.
6. Doyle J., Creager M.A. Pharmacotherapy and behavioral intervention for peripheral arterial disease. Reviews in Cardiovascular Medicine. 4:2003;18-24.
7. Elam M.B., Heckman J., Crouse J.R., Hunninghake D.B., Herd J.A., Davidson M., Gordon I.L., Bortey E.B., Forbes W.P. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arteriosclerosis, Thrombosis, and Vascular Biology. 18:1998;1942-1947.
8. Hebel R., Stromberg M.W. I. Circulatory system. Anatomy and embryology of the laboratory rat. 1986;97-116 BioMed-Verlag, Wörthsee.
9. Hiatt W.R. Current and future drug therapies for claudication. Vascular Medicine. 2:1997;257-262.
10. Igawa T., Tani T., Chijiwa T., Shiragiku T., Shimidzu S., Kawamura K., Kato S., Unemi F., Kimura Y. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thrombosis Research. 57:1990;617-623.
11. Kamiya T., Sakaguchi S. Hemodynamic effects of the antithrombotic drug cilostazol in chronic arterial occlusion in the extremities. Arzneimittel-Forschung Drug Research. 35:1985;1201-1203.
12. Kimura Y., Tani T., Kanbe T., Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittel-Forschung Drug Research. 35:1985;1144-1149.
13. Lievre M., Azoulay S., Lion L., Morand S., Girre J.P., Boissel J.P. A dose-effect study of beraprost sodium in intermittent claudication. Journal of Cardiovascular Pharmacology. 27:1996;788-793.
14. Money S.R., Herd J.A., Isaacsohn J.L., Davidson M., Cutler B., Heckman J., Forbes W.P. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. Journal of Vascular Surgery. 27:1998;267-275.
15. Porter J.M., Cutler B.S., Lee B.Y., Reich T., Reichle F.A., Scogin J.T., Strandness D.E. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. American Heart Journal. 104:1982;66-72.
16. Saltin B. Physical training in patients with intermittent claudication. Cohen L.S., Mock M.B., Ringqvist I. Physical conditioning and cardiovascular rehabilitation. 1981;181-196 Wiley, New York.
17. Solomon S.A., Ramsay L.E., Yeo W.W., Parnell L., Morris-Jones W. β blockade and intermittent claudication: Placebo controlled trial of atenolol and nifedipine and their combination. BMJ. 303:1991;1100-1104.
18. Weitz J.I., Byrne J., Clagett G.P., Farkouh M.E., Porter J.M., Sackett D.L., Strandness D.E. Jr., Taylor L.M. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review. Circulation. 94:1996;3026-3049.
19. Yasuda K., Sakuma M., Tanabe T. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans. Arzneimittel-Forschung Drug Research. 35:1985;1198-1200.